Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2022 - cell.com
Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2022 - Elsevier
HighlightsThe physiological microenvironment of the gut influences the efficacy of live
biotherapeutic products (LBPs) and both discovery and delivery strategies can be used to …

[PDF][PDF] Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2022 - par.nsf.gov
Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

Discovery and delivery strategies for engineered live biotherapeutic products.

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2021 - europepmc.org
Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

[HTML][HTML] Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2022 - ncbi.nlm.nih.gov
Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook… - Trends in …, 2022 - pubmed.ncbi.nlm.nih.gov
Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

[引用][C] Discovery and delivery strategies for engineered live biotherapeutic products

MK Heavey, D Durmusoglu, N Crook, AC Anselmo - 2022